Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol before house dust mite allergen or allergen plus LPS bronchial challenge in mild asthma
NL-OMON33541Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of salmeterol in asthma (4 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Neutrophil, eosinophil and mast cell responses, Neutrophil activation and 7 more. Planned start Sep 2008; status: not yet recruiting.
02
Drugs
salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON33541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33541.